Computationally hybridized pathogenic mammarenavirus receptor binding domains reveal cryptic variants that elicit cross-neutralizing immune responses
Lily Taylor, Gavriella Siman-Tov, Sol Ferrero, Takeshi Saito, Gustavo F. Helguera, Junki Maruyama, José A. Rodríguez
The paper investigates hybridized JUNV-MACV GP1 variants, showing they enable virus entry and are recognized by cross-neutralizing antibodies, suggesting potential for antiviral therapy design.
bioRxiv · Jun 10, 2026 · PreprintBiophysics